Hormome-suppressing therapy associated to cardiac risk in recent study.
New research suggests the male hormone-suppressing treatment used to cure aggressive prostate cancer may result on earlier heart attacks in older men.
That conclusion, which comes from analysis of pooled data of studies in the United States, New Zealand and Australia, does not mean men with agressive cancer should not be treated to suppress the action of male sex hormones that spur the growth of prostate cancer cells (androgens).
The implication is that men who need hormonal therapy treatment to avoid dying from prostate cancer but also have high risk factors for heart attack, should examind by a cardiologist for assessment and possible treatment of heart disease before having such therapy
No User Responded In This Post
Leave Your Comments Here...